Introduction
Mass spectrometers have been available for over 20 years and numerous reports have described their use for respiratory and blood gas measurements [2, 181. Although not applied previously to measurement of VA/Q inequalities in neonatal respiratory disorders, a mass spectrometer system would have unique advantages, especially in neonates who require assisted ventilation.
The purposes of this report are to (I) describe a method for continuous measurement of respired gas composition utilizing a mass spectrometer system (PFA-5 [21] ) and (2) describe the results of serial aADC02 and AaDOz measurements in 63 neonates with RDS. Although quantitative assessment of VA/Q non-uniformities, the primary cause of hypoxemia in RDS, is difficult, the magnitude of VA/Q abnormalities can be estimated from measurements of aADCO2 and AaD02.
Materials and Methods
The PFA-5 is a mobile unit which includes the following components: quadrupole mass spectrometer for gas analysis, hot film anemometer flow meter for flow measurements, and an analogue computer for calculation of VT, O2 consumption, COz production, and other respiratory parameters.
Flow measurements are achieved by directing expired gas into the inlet bf the flow meter. In children not old enough to accept the mouthpiece, flow measurements can still be obtained if the patient is intubated. Flow measurements cannot be performed in patients receiving continuous positive airway pressure (CPAP) [4] because of the flow of noninspired air through the system. Flow measurements in patients receiving intermittent positive pressure breathing (IPPB) (22) For gas analysis, the 99 % response time of the system is approximately 500 ms. Although its stability is excellent, the total drift/24 hr being less than & 2 % of the gas concentration, calibration is ordinarily repeated before each measurement. Respiratory gas sampling is achieved using a 200-cm long catheter with an internal diameter 0.3 mm. The catheter is heated to 80" to prevent water vapor condensation. The sampling rate through the catheter is about 22 cc/min.
Respired gas is sampled continuously by placing the tip of the respiratory catheter at the nose or mouth in patients breathing spontaneously or at the proximal end of the endotracheal tube in intubated patients (Fig. 1) . 02, COz, and any other three gases with a molecular weight from 2 to 99 atomic mass units can be measured simultaneously. As with VT, concentration of the dry gases is displayed on the digital voltmeters on the front panel of the PFA-5, and a graphic output can also be obtained (Fig. 2) .
AaD02 and aADCOz were obtained by matching the alveolar (end-tidal) value for each gas with a simultaneous arterial value measured by conventional methods [25] . The arterial sample was obtained from the descending aorta, if an umbilical arterial catheter was in place, or from a percutaneous arterial puncture. No AaD measurements were performed unless the patients were normothermic, had stable acid-base balance, and had no acute complications or stresses such as lobar atelectasis or pneumothorax. pao, was converted to saturation using Gomez's formula [3] , and &' Q was calculated by the standard equation. Since arteriovenous Oz saturation differences of 10 % in severe to 15 % in mild RDS have been reported [12] , we arbitrarily assumed a value of 13 % for our calculations. Of the approximately 175 RDS newborns admitted to Mass spectrometry in RDS our NICU each year, all but 5-10 % are born elsewhere and most are referred for admission only when a need for assisted ventilation is anticipated. Because of this selection of more severe RDS, the incidence of RDS requiring assisted ventilation in 1972, for example, was 66%. Survival for RDS patients in 1972 was 41 % for those who required assistance as compared with 95 % for those who did not require assistance, with an overall survival of 59 %. Assisted ventilation included any combination of CPAP, IPPB, or PEEP [6] . The indications for assisted ventilation consisted routinely of one or more of the following: ( I ) apnea or slow, gasping inadequate respirations, (2) totally opacified lung fields by thoracic roentgenogram, or (3) at an FIo, of 20.9, a pa,, of <60 mm Hg if under 12 hr of age, or <40 mm Hg at any age. Patients were initially started on CPAP and changed to a respirator when spontaneous ventilation could not be maintained and/or an FIo2 of >0.60 was required. PEEP was used in preference to IPPB whenever an FIo, of >0.30 was required with IPPB. As the clinical condition then improved, FIo2 was gradually decreased to 5 0.30 while maintaining pao2 at 50-70 mm Hg, and the end-expiratory pressure (EEP) was then gradually reduced from 10 to 0 cm HzO. If at all possible, ventilation was always adjusted so as to maintain paco2 at 40-50 mm Hg. When patients were successfully weaned from PEEP, CPAP was begun at an Fro, of 50.30 and EEP of 6-10 cm HzO, while maintaining pao, at 40-60 mm Hg; the EEP was then gradually decreased to 0 as tolerated.
Beginning in mid-1972, AaD02 and aADCOz measurements have been obtained in 120 RDS patients who required assisted ventilation and in 70 who did not require assistance. The patients included in this report are the 46 who required assisted ventilation and 17 without assistance for whom serial measurements of aADCO2 and AaDOz are available. In the nonassisted patients, the mean birth weight was 2.42 kg (k 1.08); all 17 patients survived. Among the 46 patients who required assistance, the mean birth weight was 2.17 kg (k0.57) for the 28 survivors and 1.48 kg ( h 0 . 5 3 ) for the 18 nonsurvivors.
R e s u l t s
Nonassisted RDS. Serial aADCOz changes were assessed in 17 patients who did not require assisted ventilation (Fig. 3) . Because these patients were often not admitted until they approached 24 hr of age, the initial Representative end-expiratory plateaus can be visualized easily. End-inspiratory plateaus were not achieved because of a short inspiratory duration (330 ms).
aADCOp usually could not be obtained early enough to reflect the observed changes in clinical symptoms and adequacy of ventilation that occurred before age 24 hr. The initial aADCOz varied from normal ( <5) up to 26 mm Hg. In all but three patients, aADC02 gradually improved with age as the clinical condition improved. Although the three remaining patients did improve after age 4 days, unfortunately, no later aADCOz levels were obtained.
Assisted RDS. Serial aADCO2 changes were assessed in 36 patients who required assisted ventilation (Fig. 4) , all but three of whom initially required PEEP. Eighteen of these 36 patients survived, 14 died from problems re- Right: serial measurements of aADCOz in 18 survivors. Unlike the nonsurvivors, an aADCOz of < 10 mm H g was usually achieved
by age 5-6 days.
lated to severe RDS, and 4 died of nonpulmonary problems. Although the nonpulmonary deaths are included with the other nonsurvivors, aADC02 values in these 4 were more consistent with values obtained in the puImonary survivors. The mode of assisted ventilation at the time of each aADC02 measurement is indicated. Individual initial aADCO2 values were not appreciably different from those obtained in nonassisted RDS, except that assisted ventilation was required in order to achieve these comparable levels. In the 18 survivors of severe RDS, aADC02 values of < 10 mm Hg were typically achieved by age 5 to 6 days, whereas, in the pulmonary nonsurvivors, aADCO2 tended to either remain at, or later return to, a level of 2 10 mm Hg.
Except for one older infant with a superimposed severe pneumonitis, failure to achieve and maintain an aADCO2 of < 10 mm Hg by age 7-10 days even with maximal ventilatory assistance was associated with ultimate pulmonary nonsurvival.
Nonassisted RDS. Serial AaDO2 changes, expressed as
Q,/Q, were assessed in 16 patients not requiring assisted ventilation (Fig. 5) . As with aADCO2, not enough measurements were obtained in the first 24 hr of life to define the precise age at which maximal Q,/Q is achieved. There was considerable variation in initial %/Q. In 10 patients, &/Q improved with age as the clinical condition improved. Although the other 6 patients later showed progressive clinical improvements, unfortunately no later Q,/Q measurements were obtained.
Assisted RDS. Serial measurements of AaD02, expressed as %/a, were obtained in 46 patients who required assisted ventilation (Fig. 6) ; all but 3 required PEEP during the acute illness. Of these 46 patients, 28
survived, 14 died of RDS-related problems, and 4 died of nonpulmonary problems.
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The PFA-5 was also used to obtain a more detailed Fip. 7. Serial changes in aADC02, AaD02, and QJQ as a function of age, FIo2, inspiratory pressure and rate, and end-expiratory pressure (EEP) in two premature infants with severe respiratory distress syndrome (RDS) requiring positive-end-expiratory pressure assistance (PEEP). A: survivor: PEEP was required a t age 11 hr, and continued until 7.5 days of age. Q./Q was maximal at lf! hr and then gradually decreased. aADCOz during the first 24 hr of assistance ranged from 4 to 7 mm Hg; the subsequent decrease to 0 could be related to either lung improvement or to the decrease in EEP. 3: nonsurvivor: PEEP was required at 4 hr of age; death occurred at age 5.2 days. After the achievement of maximal Q,/Q and aADCOz a t 16 hr of age, both aADCOz and Q,/Q subsequently decreased to low levels but then, unlike the survivor, progressively increased again thereafter. Autopsy revealed RDS and intraventricular hemorrhage.
the survivor. In the nonsurvivor, however, after a temjust AaDOr values are presented. The use of Q$Q rather porary decrease to low levels, both aADCO2 and Q,/Q than AaD02 has been justified on theoretical grounds increased progressively thereafter.
[ For gas analysis, the PFA-5 has a total response time of approximately 500 ms. Because of faster respiratory rates and smaller VT in infants, a potential concern is that this response time would be too slow to allow for true end-tidal sampling, thereby overestimating pAo2 and underestimating pAco, As illustrated (Fig. 2) , however, true end-expiratory plateaus can generally be achieved even though inspiratory duration may be < 500 ms and an accurate analysis of end-inspiratory pO2 and p C 0 2 cannot be obtained.
Obtaining pao2 samples representative of pulmonary venous blood is another potential concern. Since the arterial sample used for AaDOa measurements was ordinarily obtained from an umbilical arterial catheter positioned in the lower thoracic aorta, at least during the first 48-72 hr of life, AaD02 would be overestimated if right-to-left shunts through the foramen ovale and/or ductus arteriosus (fetal shunts) are also present. Since fetal shunts seldom persist beyond 48-72 hr of age, however, and are seldom significant in those with severe RDS [7] (in which case a large intrapulmonary Qs/Q is already present [lo, 19] ), it is not likely that Q,/Q has been overestimated significantly in our patients with severe RDS. Although the magnitude of the overestimation can be expected to be greater in mild (nonassisted) as compared with severe (assisted) RDS, significant differences in G/Q as measured from pulmonary vein and descending aorta have not generally occurred after 3 days of age [7] . Inasmuch as the arteriovenous pCOz difference is only 4-6 mm Hg, aADCO2 is essentially unaffected by fetal shunts, and blood from the descending aorta, therefore, should always be representative of pulmonary venous blood.
The AaDO2 data have been presented as intrapulrnonary &/Q because less variability exists than when formity [17] . The aADC02 and AaDO? data obtained in these RDS patients provides additional confirmation of (I) the presence of low VA/Q regions in the lung, accounting for the intrapulmonary Q,/Q [5, [14] [15] 191 , and (2) the presence of high VA/Q regions, as indicated by elevated aADC02 levels. In addition to the information which could be derived from serial AaDN2 measurements [l, 8, 91 , further conclusions regarding VA/Q inequalities in RDS will require earlier and more frequent measurements of AaD than was achieved in the patients reported here.
Evaluation of the RDS patient who cannot be weaned from assisted ventilation has been a major clinical problem. No objective method for assessing respiratory function in these patients has been available. Although AaDO2 measurements do not appear to be helpful at the present time, our data indicates a correlation between ability to achieve an aADC02 of < 10 mm Hg by age 7-10 days and pulmonary survival. Ongoing studies are in progress to further evaluate the prognostic significance of aADCO2 in the acute as well as in the convalescent phase of RDS.
Summary
A mass spectrometer system capable of simultaneous, continuous measurement of any five respiratory gases in patients of any age or clinical condition has been utilized for measurement of pAcoz and pAo2.
VA/Q inequalities have been evaluated in 63 patients by serial assessments of aADCO2 and AaDOe (expressed as Q/Q) in assisted as well as nonassisted patients. Our preliminary data indicates that aADCO2 levels may be of significance in defining potential for pulmonary survival in RDS patients.
